Thoratec warns doctors about external placement of IVAD
This article was originally published in Clinica
Executive Summary
Thoratec, the developer of therapies for advanced-stage heart failure, has warned patients against the external use of its heart-assist device as this could result in potentially fatal complications arising from problems with the pneumatic driveline.